StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Mizuho Securities Downgrades Allergen (AGN) to Neutral
April 6, 2016 6:25 AM
Mizuho Securities downgraded Allergen (NYSE: AGN) from Buy to Neutral with a price target of $250.00 (from $330.00), as they ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Downgrades
Rumors
Next Articles
Piper Jaffray Sees Value in Allergen (AGN) Post-Pfizer; PT to $311
April 6, 2016 11:29 AM
Leerink Partners Cuts Price Target on Allergan (AGN) Following New U.S. Treasury Regulations
April 6, 2016 7:13 AM
Allergan (AGN) Affirms Termination of Pfizer (PFE) Merger; Affirms Strength as Standalone Company
April 6, 2016 6:47 AM
Allergen's (AGN) Stand-Alone Price Target is $282 at Deutsche Bank
April 5, 2016 3:45 PM
